FDA gives tentative approval for Perrigo OTC pain drugs
ALLEGAN, Mich. The Food and Drug Administration has given Perrigo tentative approval for its OTC ibuprofen and diphenhydramine citrate tablets, Perrigo announced Wednesday.
The product, available in 200 mg and 38 mg doses, will be sold under private labels and is comparable to Wyeths Advil PM pain-relief tablets.
“This is another example of Perrigo’s investment in new products making quality healthcare more affordable to American consumers,” Perrigo chairman and chief executive officer Joseph Papa said in a statement. “This is an important addition to our portfolio of products that saves the consumer of our OTC healthcare products approximately $1 billion annually when compared to the higher priced national brands.”
Biocodex releases Florastor in 20-count packs in time for cold-flu season
SAN BRUNO, Calif. Biocodex has announced that its Florastor digestive health probiotic product now is available in 20-count blister packs for retail sale. The smaller box is easier to carry and more convenient than the larger size glass bottle of 50 capsules.
The key ingredient—Saccharomyces boulardii—in yeast-based Florastor and Florastor Kids helps protect the guts by promoting “good bacteria” to aid in digestion.
Probiotics can help as a supplemental treatment for those taking antibiotics which can have severe, uncomfortable side effects, such as diarrhea.
Biocodex explained that the updated packaging was designed for portability and availability on chain drug store shelves.
“We’re very excited about our change in packaging with the new Florastor blister packs,” Mary Berry, U.S. marketing manager for Biocodex said. “We felt our consumers would prefer a 20-count box because, at two capsules per day, it coincides with the standard 10-day course of antibiotics to protect against antibiotic-associated diarrhea, a common side effect of antibiotic treatment. The blister packs make it easier for people to protect their stomachs by carrying Florastor with them wherever they are.”
‘Grey’s Anatomy’ star joins campaign to educate parents on children’s cough-cold dosing
The Consumer Healthcare Products Association unveiled a series of public service announcements Tuesday featuring Chandra Wilson, a star of the ABC drama “Grey’s Anatomy.”
The PSAs concern the safe use of children’s OTC oral cough and cold medicines and are designed to provide parents and caregivers with tips to follow when administering the medicines to children and are part of CHPA’s “Treat with Care” campaign.
“As parents, we’re in charge of our children’s health, and as a mother of three, I take this responsibility very seriously,” Wilson said. “Many of us rely on OTC cough and cold medicines to help our children feel better when they’re sick.”
The medicines are safe and effective for children when used as directed, CHPA said, but could carry risks if used or stored incorrectly.
“For decades, parents have relied on pediatric OTC cough and cold medicines to relieve their children’s cough and cold symptoms,” CHPA president Linda Suydam said. “When used properly, these medicines are safe and effective, and the ‘Treat with Care’campaign underscores the importance of continuing to use these medicines safely in children.”